Search
About
Mission & Vision
Executive Team
Board of Directors
Scientific Advisory Board
ESG
Collaborations
Platforms
About ADCs
Dolasynthen
Immunosynthen
Pipeline
Overview
XMT-1660
XMT-2056
Publications
Investors & Media
Overview
Stock
Analysts
SEC Filings
News
Events
Annual Meeting
Governance
Quarterly Results
Contact Us
People
Culture
Benefits
Careers
Contact
Search for:
Other
,
Other
,
Publications
XMT-1536 Phase 1 Dose Escalation Study
March, 2020
Read More
